Mortality benefit of primary transportation to PCI capable centre persists through eight-year follow-up in patients with ST-segment elevation myocardial infarction.
Elevated microRNA-499 level in early phase of non-ST elevation acute coronary syndromes predicts increased long-term risk of major adverse cardiac events.